RxDoctor Payments Data

Stephanie Whitmer, MD

Family Medicine · Morris, ILNPI 1386905446

Payments from drug & device makers

$924in general payments, 2019–2025

Across 54 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$208
  • Lilly USA, LLC$156
  • AbbVie$134
  • Boehringer Ingelheim$99
  • Amgen$97
  • Novartis$60
  • plus $170 from 10 others

What the payments were for

  • Food & beverage$924100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$924 in reported general payments places this provider in the 70th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$2,050
Medicare patients
92
Services billed
196

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide89$100,881
MounjaroTirzepatide58$66,940
TrulicityDulaglutide57$55,846
JardianceEmpagliflozin38$37,055
EliquisApixaban53$36,418
LinzessLinaclotide35$31,177
JanuviaSitagliptin Phosphate35$27,407
UbrelvyUbrogepant15$18,285
Emgality PenGalcanezumab-Gnlm21$14,734
Breo ElliptaFluticasone/Vilanterol32$13,528
XareltoRivaroxaban16$12,296
Spiriva HandihalerTiotropium Bromide13$11,571
MyrbetriqMirabegron18$10,989
ArexvyRsvpref3 Antigen/As01e/Pf21$5,852
BelsomraSuvorexant11$4,752

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$156$122,786115 claims
Novo NordiskOzempic$208$100,88189 claims
AbbVieLinzess, Ubrelvy, Synthroid$134$50,38473 claims
Boehringer IngelheimJardiance$99$37,05538 claims
PfizerEliquis$20$36,41853 claims
GSKBreo Ellipta, Arexvy, Shingrix$15$22,15367 claims
Astellas Pharma US IncMyrbetriq$15$10,98918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Morris

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →